KRONOS BIO

kronos-bio-logo

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.
#SimilarOrganizations #People #Financial #Event #Website #More

KRONOS BIO

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Chemical Therapeutics

Founded:
2017-01-01

Address:
San Mateo, California, United States

Country:
United States

Website Url:
http://www.kronosbio.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
278 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins


Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.


Current Advisors List

jakob-loven_image

Jakob Loven Board of Directors @ Kronos Bio
Board_member

marianne-de-backer_image

Marianne De Backer Member Board of Directors @ Kronos Bio
Board_member
2021-01-01

Current Employees Featured

angela-koehler_image

Angela Koehler
Angela Koehler Scientific Founder @ Kronos Bio
Scientific Founder
2017-11-01

christopher-wilfong_image

Christopher Wilfong
Christopher Wilfong Chief Operating Officer and Co-Founder @ Kronos Bio
Chief Operating Officer and Co-Founder
2017-11-01

norbert-bischofberger_image

Norbert Bischofberger
Norbert Bischofberger President & Chief Executive Officer @ Kronos Bio
President & Chief Executive Officer
2018-08-01

jorge-dimartino_image

Jorge DiMartino
Jorge DiMartino Chief Medical Officer & Executive Vice President, Clinical Development @ Kronos Bio
Chief Medical Officer & Executive Vice President, Clinical Development
2019-12-01

douglas-c-saffran_image

Douglas C. Saffran
Douglas C. Saffran Vice President, Pharmacology @ Kronos Bio
Vice President, Pharmacology
2018-08-01

zung-to_image

Zung To
Zung To Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality @ Kronos Bio
Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality
2020-05-01

wes-trotter_image

Wes Trotter
Wes Trotter Vice President, Chemistry @ Kronos Bio
Vice President, Chemistry
2020-01-01

charles-lin_image

Charles Lin
Charles Lin Vice President, Biology @ Kronos Bio
Vice President, Biology
2019-12-01

christopher-lee_image

Christopher Lee
Christopher Lee Vice President, Program Management @ Kronos Bio
Vice President, Program Management

yasir-b-al-wakeel_image

Yasir B. Al-Wakeel
Yasir B. Al-Wakeel CFO & Head of Corporate Development @ Kronos Bio
CFO & Head of Corporate Development
2020-01-01

Founder


angela-koehler_image

Angela Koehler

christopher-wilfong_image

Christopher Wilfong

joshua-kazam_image

Joshua Kazam

Stock Details


Company's stock symbol is NASDAQ:KRON

Investors List

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Private Equity Round - Kronos Bio

vida-ventures_image

Vida Ventures

Vida Ventures investment in Private Equity Round - Kronos Bio

commodore-capital_image

Commodore Capital

Commodore Capital investment in Private Equity Round - Kronos Bio

woodline-partners_image

Woodline Partners

Woodline Partners investment in Private Equity Round - Kronos Bio

nextech-invest_image

Nextech Invest

Nextech Invest investment in Private Equity Round - Kronos Bio

invus_image

Invus

Invus investment in Private Equity Round - Kronos Bio

google-ventures_image

GV

GV investment in Private Equity Round - Kronos Bio

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Private Equity Round - Kronos Bio

blackrock_image

BlackRock

BlackRock investment in Private Equity Round - Kronos Bio

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Private Equity Round - Kronos Bio

Official Site Inspections

http://www.kronosbio.com Semrush global rank: 4.57 M Semrush visits lastest month: 2.27 K

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kronos Bio" on Search Engine

dfkcompany.com © 2022. All rights reserved